Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neurological Associates of West Los Angeles
The present open-label study is being undertaken to evaluate focused transcranial ultrasound therapy as an intervention for patients with neuropathic pain. The subjects in this research study will be recruited through medical practice. Participants who are enrolled will undergo 8 consecutive weekly ultrasound sessions. Targeting for treatment will be based on patient MRI scans using stereotaxic techniques.
Age
18–90
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
History of neuropathic pain (onset, location, intensity, duration, quality, aggravating factors)
Confirmation of nervous system injury through imaging or negative or positive sensory signs confined to the corresponding bodily area
Failure from at least 3 pharmacological treatments (e.g., antidepressants, anticonvulsants, opioids)
At least 18 years of age
You may not be if
Subjects unable to give informed consent
Subjects who would not be able to lay down without excessive movement in a calm environment
Pregnancy, women who may become pregnant or are breastfeeding
Subjects with scalp rash or open wounds on the scalp (for example from treatment of squamous cell cancer)
Clareo Health | Focused Ultrasound for the Treatment of Neuropathic Pain
